NCT06923826
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +11 more
- Locations
-
- National University Cancer Institute Singapore Singapore
Clinical trial condition
Salivary Gland Neoplasms
Explore clinical trials studying Salivary Gland Neoplasms. Study availability and eligibility vary by location and protocol.
190 public trials
22 recruiting studies
Salivary Gland Neoplasms trial results
NCT04214366
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +11 more
- Locations
-
- University of Heidelberg, Radiooncology, HIT Heidelberg, Germany
Not Yet Recruiting
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
NCT07667400
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +46 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Not Yet Recruiting
Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers
NCT06091878
- Conditions
- Head and Neck Neoplasms, Mouth Diseases, Mouth Neoplasms, +6 more
- Locations
-
Not specified
Not Yet Recruiting
Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations
NCT06519110
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +30 more
- Locations
-
Not specified
NCT05946577
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Chemically-Induced Disorders, +28 more
- Locations
-
- Radiotherapy Oncology Service TENON Hospital Paris, France
NCT02576431
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +43 more
- Locations
-
- Stanford Cancer Center Palo Alto Palo Alto, California, United States
- UCLA Health Santa Monica Cancer Care Santa Monica, California, United States
- Memorial Cancer Institute at West Pembroke Pines, Florida, United States
- The University of Chicago Medical Center - Hyde Park - Hematology & Oncology Chicago, Illinois, United States
Completed
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
NCT05694819
- Conditions
- Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Nagoya University Hospital Nagoya, Aichi-ken, Japan
- Chiba University Hospital Chiba, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- National Hospital Organization Kyushu Medical Center Fukuoka, Japan
Completed
Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
NCT00939627
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Suburban Hospital Bethesda, Maryland, United States
NCT02589938
- Conditions
- Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +24 more
- Locations
-
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
- Kaiser Permanente-San Francisco San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose San Jose, California, United States
- Kaiser Permanente-San Rafael San Rafael, California, United States